Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|August 29, 2025
PD-1 Bispecific Killer Engager (PD-1 BiKE) effectively depletes effector T lymphocytes in experimental autoimmune encephalomyelitisLauren C Naatz, Shuyun Dong, Yujia Zhai, et al.
Biomaterials|April 10, 2016
An iTEP-salinomycin nanoparticle that specifically and effectively inhibits metastases of 4T1 orthotopic breast tumorsPeng Zhao, Guiquan Xia, Shuyun Dong, et al.
Acta Pharmaceutica Sinica. B|May 15, 2025
Bispecific killer engager for targeted depletion of PD-1 positive lymphocytes: A new avenue for autoimmune disease treatmentLauren C Naatz, Shuyun Dong, Brian Evavold, et al.
Theranostics|March 30, 2016
A Comparison Study of iTEP Nanoparticle-Based CTL Vaccine Carriers Revealed a Surprise Relationship between the Stability and Efficiency of the CarriersShuyun Dong, Tiefeng Xu, Peng Zhao, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 12, 2022
Antibody-mediated depletion of programmed death 1-positive (PD-1+) cellsYujia Zhai, Shuyun Dong, Haojia Li, et al.
Molecular Pharmaceutics|March 28, 2017
An Anti-Programmed Death-1 Antibody (αPD-1) Fusion Protein That Self-Assembles into a Multivalent and Functional αPD-1 NanoparticlePeng Zhao, Djordje Atanackovic, Shuyun Dong, et al.
Protein Science : a Publication of the Protein Society|July 29, 2023
Diphtheria toxin-derived, anti-PD-1 immunotoxin, a potent and practical tool to selectively deplete PD-1+ cellsTianxiao Zhang, Shuyun Dong, Yujia Zhai, et al.
Molecular Cell|December 24, 2003
Genome-wide analysis of mRNAs regulated by the nonsense-mediated and 5' to 3' mRNA decay pathways in yeastFeng He, Xiangrui Li, Phyllis Spatrick, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 8, 2013
Treatment of type 1 myotonic dystrophy by engineering site-specific RNA endonucleases that target (CUG)(n) repeatsWenjing Zhang, Yang Wang, Shuyun Dong, et al.
Theranostics|January 2, 2018
An Albumin-binding Polypeptide Both Targets Cytotoxic T Lymphocyte Vaccines to Lymph Nodes and Boosts Vaccine Presentation by Dendritic CellsPeng Wang, Peng Zhao, Shuyun Dong, et al.
Pageof 3